| Year |
Citation |
Score |
| 2019 |
Valdez CA, Leif RN, Hok S. Carbene-based Difluoromethylation of Bisphenols: Application to the Instantaneous Tagging of Bisphenol A in Spiked Soil for Its Detection and Identification by Electron Ionization Gas Chromatography-Mass Spectrometry. Scientific Reports. 9: 17360. PMID 31758017 DOI: 10.1038/S41598-019-53735-9 |
0.302 |
|
| 2016 |
Balhorn R, Adrichem AJv, Hok S, Balhorn MC. Abstract 2991: Inhibition of Rac1 GTPase activity by SH7139, a new drug candidate for non-Hodgkin's lymphoma targeting HLA-DR10 Cancer Research. 76: 2991-2991. DOI: 10.1158/1538-7445.Am2016-2991 |
0.353 |
|
| 2015 |
Balhorn MC, Hok S, Balhorn R. Abstract 5498: Multiple mechanisms of action may contribute to the lymphoma cell-killing activity of SH7139 Cancer Research. 75: 5498-5498. DOI: 10.1158/1538-7445.Am2015-5498 |
0.368 |
|
| 2015 |
Balhorn R, Hok S, Balhorn MC. Abstract 4494: Physical and metabolic stability of SH7139, a new drug candidate for non-Hodgkin's lymphoma targeting HLA-DR10 Cancer Research. 75: 4494-4494. DOI: 10.1158/1538-7445.Am2015-4494 |
0.346 |
|
| 2014 |
Balhorn MC, Mirick G, Cheng D, Ma Z, Lau EY, Hok S, DeNardo GL, Balhorn R. Abstract 5460: Intracellular uptake and metabolism of SH7139: Is it a targeted prodrug for B-cell lymphomas Cancer Research. 74: 5460-5460. DOI: 10.1158/1538-7445.Am2014-5460 |
0.38 |
|
| 2014 |
Balhorn R, Mirick G, DeNardo GL, Beckett L, Li J, Hok S, Balhorn M. Abstract 2703: Effect of route and dosing regimen on efficacy of SH7139 in mouse Burkitt's lymphoma xenografts Cancer Research. 74: 2703-2703. DOI: 10.1158/1538-7445.Am2014-2703 |
0.329 |
|
| 2013 |
Balhorn R, Hok S, Balhorn M. Abstract 4419: Pilot toxicology study of the B-cell lymphoma drug candidate SH7139 demonstrates lack of toxicity in beagles. Cancer Research. 73: 4419-4419. DOI: 10.1158/1538-7445.Am2013-4419 |
0.314 |
|
| 2013 |
Balhorn M, Hok S, Balhorn R. Abstract 2453: Optimizing a modular synthetic approach for producing SH7139, a new drug candidate for treating B-cell lymphomas. Cancer Research. 73: 2453-2453. DOI: 10.1158/1538-7445.Am2013-2453 |
0.35 |
|
| 2012 |
Balhorn R, Rebhun RB, Hok S, Baum R, Sanger J, Balhorn MC. Abstract 4591: Biotinylated derivatives of selective high affinity ligand (SHAL) therapeutics as companion diagnostics for prescreening non-Hodgkin's lymphoma patients Cancer Research. 72: 4591-4591. DOI: 10.1158/1538-7445.Am2012-4591 |
0.4 |
|
| 2010 |
Balhorn RL, Skorupski KA, Hok S, Balhorn MC, Guerrero T, Rebhun RB. A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomas Veterinary Immunology and Immunopathology. 137: 235-242. PMID 20576295 DOI: 10.1016/J.Vetimm.2010.05.014 |
0.347 |
|
| 2009 |
Balhorn R, Hok S, DeNardo S, Natarajan A, Mirick G, Corzett M, DeNardo G. Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells Molecular Cancer. 8. PMID 19383174 DOI: 10.1186/1476-4598-8-25 |
0.328 |
|
| 2009 |
DeNardo GL, Mirick GR, Hok S, DeNardo SJ, Beckett LA, Adamson GN, Balhorn RL. Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia International Journal of Oncology. 34: 511-516. PMID 19148487 DOI: 10.3892/Ijo_00000176 |
0.349 |
|
| 2008 |
DeNardo GL, Natarajan A, Hok S, Mirick G, DeNardo SJ, Corzett M, Sysko V, Lehmann J, Beckett L, Balhorn R. Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging Cancer Biotherapy and Radiopharmaceuticals. 23: 783-795. PMID 20443696 DOI: 10.1089/Cbr.2008.0589 |
0.387 |
|
| 2007 |
Balhorn R, Hok S, Burke PA, Lightstone FC, Cosman M, Zemla A, Mirick G, Perkins J, Natarajan A, Corzett M, DeNardo SJ, Albrecht H, Gregg JP, DeNardo GL. Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: Initial application to lymphoma/leukemia Clinical Cancer Research. 13: 5621s-5628s. PMID 17875798 DOI: 10.1158/1078-0432.Ccr-07-1128 |
0.363 |
|
| 2007 |
DeNardo GL, Hok S, Natarajan A, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Yuan A, Perkins J, Sysko VV, Lehmann J, Balhorn RL. Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma International Journal of Oncology. 31: 729-740. PMID 17786303 DOI: 10.3892/Ijo.31.4.729 |
0.394 |
|
| 2007 |
DeNardo GL, Natarajan A, Hok S, Perkins J, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Miers LA, Balhorn RL. Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma Journal of Nuclear Medicine. 48: 1338-1347. PMID 17631545 DOI: 10.2967/Jnumed.107.041095 |
0.36 |
|
| 2007 |
Hok S, Natarajan A, Balhorn R, DeNardo SJ, DeNardo GL, Perkins J. Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia Bioconjugate Chemistry. 18: 912-921. PMID 17373772 DOI: 10.1021/Bc060305O |
0.41 |
|
| 2006 |
West J, Perkins J, Hok S, Balhorn R, Lightstone FC, Cosman M, DeNardo SJ, DeNardo GL. Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells Cancer Biotherapy and Radiopharmaceuticals. 21: 645-654. PMID 17257080 DOI: 10.1089/Cbr.2006.21.645 |
0.4 |
|
| 2006 |
Hok S, Schore NE. Synthesis of 2-arylcycloalka-2,4-dienones using sulfone-based methodology. The Journal of Organic Chemistry. 71: 1736-8. PMID 16468837 DOI: 10.1021/Jo0523262 |
0.53 |
|
| 2005 |
Song Y, Haddad RE, Jia SL, Hok S, Olmstead MM, Nurco DJ, Schore NE, Zhang J, Ma JG, Smith KM, Gazeau S, Pécaut J, Marchon JC, Medforth CJ, Shelnutt JA. Energetics and structural consequences of axial ligand coordination in nonplanar nickel porphyrins. Journal of the American Chemical Society. 127: 1179-92. PMID 15669857 DOI: 10.1021/Ja045309N |
0.541 |
|
| 2002 |
Hok S, Vassilian J, Schore NE. Catalytically active, recyclable zirconocene supported at cross-links within porous polymer disks. Organic Letters. 4: 2365-8. PMID 12098248 DOI: 10.1021/Ol026094U |
0.517 |
|
| Show low-probability matches. |